<DOC>
	<DOCNO>NCT01690455</DOCNO>
	<brief_summary>This observational , multi-center study evaluate efficacy safety Mircera ( methoxy polyethylene glycol-epoetin beta ) renal anemia correction dialyse patient daily clinical practice . Patient receive Mircera accord local summary product characteristic . Data collect 12 month .</brief_summary>
	<brief_title>An Observational Study Mircera Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Adult patient , &gt; /=18 year age Adequate iron status Signed informed consent form Anemia due nonrenal cause Where investigator consider patient unsuitable inclusing reason ( e.g . severe comorbidities active bleeding , infection cancer ) Pregnant lactate female patient Any contraindication treatment Mircera ( accord local Summary Product Characteristics )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>